Key points are not available for this paper at this time.
This analysis suggests that levosimendan might reduce renal injury in adult patients undergoing cardiac surgery. More prospective randomized studies are needed to further demonstrate the benefits of levosimendan on renal protection in cardiac surgery.
Eckhardt et al. (Tue,) studied this question.